Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Posttransplant malignancy.

Jennifer Trofe1, Thomas M Beebe, Joseph F Buell

  • 1Israel Penn International Transplant Tumor Registry, University of Cincinnati, Cincinnati, Ohio, USA.

Progress in Transplantation (Aliso Viejo, Calif.)
|October 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Cost-Savings Realized Using Rabbit Anti-Thymocyte Globulin Ideal Body Weight Dosing for Kidney Transplantation Induction Immunosuppression.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same author

Not all reference samples are equal in single-cell transcriptomics of human kidney tissue.

JCI insight·2026
Same author

Patient-reported Opioid use and Pain Management After Living Kidney Donation.

Transplantation direct·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

Be a Limitless Pharmacist: Remarks by the 2025 Paul F. Parker Medalist.

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026
Same journal

End-of-Life Care of Young Adult Solid Organ Transplant Recipients Compared to Nontransplant Recipients.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same journal

A Qualitative Study on the Experiences Related to Immunosuppressive Therapy in Liver Transplant Recipients.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same journal

The Impact of Failed Deceased Donor Kidney Graft Longevity on Mortality.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same journal

The Effect of Inhaled Anesthetic Administration on Deceased Organ Donors and Transplant Recipients.

Progress in transplantation (Aliso Viejo, Calif.)·2026
Same journal

A Scoping Review and Practical Approach to Measuring Health Literacy in Solid Organ Transplantation.

Progress in transplantation (Aliso Viejo, Calif.)·2026
See all related articles

Solid-organ transplantation survival has improved, but chronic immunosuppression increases posttransplant malignancy risk. This review covers common malignancies and their prevention and treatment strategies.

Area of Science:

  • Transplantation immunology and oncology

Background:

  • Solid-organ transplantation has seen significant advances, improving patient and graft survival.
  • Modern immunosuppression and surgical techniques enhance transplant outcomes.
  • Increased survival leads to prolonged immunosuppression, raising the risk of posttransplant malignancies.

Purpose of the Study:

  • To review common posttransplant malignancies.
  • To discuss current strategies for preventing and treating these cancers.

Main Methods:

  • Literature review of posttransplant malignancies.
  • Analysis of prevention and treatment modalities.

Main Results:

  • Posttransplant malignancies are an increasing concern due to improved survival and aging recipients.

Related Experiment Videos

  • Common malignancies and their risk factors are identified.
  • Current prevention and treatment approaches are summarized.

    • Conclusions:

    • Managing the risk of posttransplant malignancy is crucial for long-term transplant success.
    • Early detection and tailored treatment strategies are essential.
    • Further research is needed to optimize cancer surveillance and management in transplant recipients.